Company broadens service offerings and strengthens network by purchasing Catalent's Center-of-Excellence for Small Molecule Analytical Services facility in North Carolina MINNEAPOLIS, MN ...
MINNEAPOLIS, September 26, 2024 (Newswire.com) - Pace ® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO) and a Division of Pace ®, a Science and Technology Company, ...
Fintel on MSN23d
Baird Downgrades Catalent (CTLT)Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...
Robert W. Baird analyst Eric Coldwell downgraded the rating on Catalent (CTLT – Research Report) to a Hold today, setting a price target of $63.50. Eric Coldwell has given his Hold rating due to ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Investors might want to bet on Catalent (CTLT), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback